Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

9.865 -0.175 (-1.74%)
Streaming Delayed Price Updated: 3:35 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce Third Quarter Financial Results on November 4, 2021
From Personalis, Inc.
Via Business Wire
News headline image
Notable Personalis Insider Makes $1.9M Sale ↗
Stephen John West, President And CEO at Personalis (NASDAQ:PSNL), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4 filing from the... 
Via Benzinga
Topics Regulatory Compliance
News headline image
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
From Personalis, Inc.
Via Business Wire
News headline image
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing
From Personalis Inc.
Via Business Wire
News headline image
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying ↗
The CEO of ARK Invest is averaging down on these compelling life-science stocks. 
Via The Motley Fool
News headline image
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
From Personalis, Inc.
Via Business Wire
News headline image
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought ↗
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover. 
Via The Motley Fool
News headline image
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development
From Personalis
Via Business Wire
News headline image
Return on Capital Employed Insights for Personalis ↗
Pulled from Benzinga Pro data Personalis (NASDAQ:PSNL) reported Q2 sales of $21.67 million. Earnings fell to a loss of $14.95 million, resulting in a 19.67% decrease from last... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
Recap: Personalis Q2 Earnings ↗
Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.24% year over year to... 
Via Benzinga
News headline image
Personalis Reports Second Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
From Personalis, Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 4, 2021 ↗
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
News headline image
Personalis to Announce Second Quarter Financial Results on August 4, 2021
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces NeXT Level Biomarkers Symposium
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
From Personalis, Inc.
Via Business Wire
News headline image
Personalis, Inc. to Present at Biomarkers Week Online 2021
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Reports First Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Present at the 2021 Bank of America Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.